View in EDS HTML Full Text PDF Full Text

Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis.

Saved in:
Bibliographic Details
Title: Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis.
Authors: Murase JE; Department of Dermatology, University of California, San Francisco, California, USA.; Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, California, USA., Eyerich K; Department of Dermatology and Venerology, Medical Center, University of Freiburg, DE., Chovatiya R; Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, USA.; Center for Medical Dermatology and Immunology Research, Chicago, USA., Hong HC; Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, Canada., Bangert C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Strowd L; Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, USA., Deleuran M; Department of Clinical Medicine - The Department of Dermatology and Venereology, Aarhus University Hospital, Aarhus, Denmark., Atwater AR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA., Rueda MJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA., Elmaraghy H; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA., Piruzeli MLB; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA., Pau-Charles I; Almirall R&D, Barcelona, Spain., Yang FE; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA., Zhong J; IQVIA, Durham, USA., Staumont-Sallé D; Department of Dermatology, University of Lille, Lille, France.
Source: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2492188. Date of Electronic Publication: 2025 Jul 24.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40708237
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Murase+JE%22">Murase JE</searchLink>; Department of Dermatology, University of California, San Francisco, California, USA.; Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, California, USA.<br /><searchLink fieldCode="AU" term="%22Eyerich+K%22">Eyerich K</searchLink>; Department of Dermatology and Venerology, Medical Center, University of Freiburg, DE.<br /><searchLink fieldCode="AU" term="%22Chovatiya+R%22">Chovatiya R</searchLink>; Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, USA.; Center for Medical Dermatology and Immunology Research, Chicago, USA.<br /><searchLink fieldCode="AU" term="%22Hong+HC%22">Hong HC</searchLink>; Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Bangert+C%22">Bangert C</searchLink>; Department of Dermatology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Strowd+L%22">Strowd L</searchLink>; Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, USA.<br /><searchLink fieldCode="AU" term="%22Deleuran+M%22">Deleuran M</searchLink>; Department of Clinical Medicine - The Department of Dermatology and Venereology, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Atwater+AR%22">Atwater AR</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Rueda+MJ%22">Rueda MJ</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Elmaraghy+H%22">Elmaraghy H</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Piruzeli+MLB%22">Piruzeli MLB</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Pau-Charles+I%22">Pau-Charles I</searchLink>; Almirall R&D, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Yang+FE%22">Yang FE</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Zhong+J%22">Zhong J</searchLink>; IQVIA, Durham, USA.<br /><searchLink fieldCode="AU" term="%22Staumont-Sallé+D%22">Staumont-Sallé D</searchLink>; Department of Dermatology, University of Lille, Lille, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228918133%22">The Journal of dermatological treatment</searchLink> [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2492188. <i>Date of Electronic Publication: </i>2025 Jul 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8918133 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-1753 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209546634%22">09546634 </searchLink><i>NLM ISO Abbreviation: </i>J Dermatolog Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40708237
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09546634.2025.2492188
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2492188
    Titles:
      – TitleFull: Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Murase JE
      – PersonEntity:
          Name:
            NameFull: Eyerich K
      – PersonEntity:
          Name:
            NameFull: Chovatiya R
      – PersonEntity:
          Name:
            NameFull: Hong HC
      – PersonEntity:
          Name:
            NameFull: Bangert C
      – PersonEntity:
          Name:
            NameFull: Strowd L
      – PersonEntity:
          Name:
            NameFull: Deleuran M
      – PersonEntity:
          Name:
            NameFull: Atwater AR
      – PersonEntity:
          Name:
            NameFull: Rueda MJ
      – PersonEntity:
          Name:
            NameFull: Elmaraghy H
      – PersonEntity:
          Name:
            NameFull: Piruzeli MLB
      – PersonEntity:
          Name:
            NameFull: Pau-Charles I
      – PersonEntity:
          Name:
            NameFull: Yang FE
      – PersonEntity:
          Name:
            NameFull: Zhong J
      – PersonEntity:
          Name:
            NameFull: Staumont-Sallé D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1471-1753
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The Journal of dermatological treatment
              Type: main
ResultId 1